With shorter patents, or no patents, the business model changes. What is changes to is hard to predict. However, we can guess that drugs would price out LESS on average due to generics coming in sooner.
In the absence of patents, who is going to pay for the expenses of developing the medicine? It's not hard to predict that smart people don't work for free, nor is specialized lab equipment available for free.
